- Home
- HASI vs FOLD Comparison
HASI vs FOLD Comparison
Compare HASI & FOLD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HASI
- FOLD
- Stock Information
- Founded
- HASI 1981
- FOLD 2002
- Country
- HASI United States
- FOLD United States
- Employees
- HASI N/A
- FOLD N/A
- Industry
- HASI Real Estate Investment Trusts
- FOLD Biotechnology: Pharmaceutical Preparations
- Sector
- HASI Real Estate
- FOLD Health Care
- Exchange
- HASI Nasdaq
- FOLD Nasdaq
- Market Cap
- HASI 3.2B
- FOLD 2.8B
- IPO Year
- HASI 2013
- FOLD 2007
- Fundamental
- Price
- HASI $27.55
- FOLD $9.51
- Analyst Decision
- HASI Strong Buy
- FOLD Strong Buy
- Analyst Count
- HASI 12
- FOLD 8
- Target Price
- HASI $39.67
- FOLD $17.00
- AVG Volume (30 Days)
- HASI 954.4K
- FOLD 2.1M
- Earning Date
- HASI 02-13-2025
- FOLD 02-26-2025
- Dividend Yield
- HASI 6.00%
- FOLD N/A
- EPS Growth
- HASI 358.98
- FOLD N/A
- EPS
- HASI 1.82
- FOLD N/A
- Revenue
- HASI $139,077,000.00
- FOLD $493,671,000.00
- Revenue This Year
- HASI N/A
- FOLD $34.33
- Revenue Next Year
- HASI $7.51
- FOLD $21.70
- P/E Ratio
- HASI $15.17
- FOLD N/A
- Revenue Growth
- HASI 14.37
- FOLD 32.58
- 52 Week Low
- HASI $22.59
- FOLD $8.79
- 52 Week High
- HASI $36.56
- FOLD $14.03
- Technical
- Relative Strength Index (RSI)
- HASI 45.92
- FOLD 48.87
- Support Level
- HASI $26.07
- FOLD $8.79
- Resistance Level
- HASI $28.47
- FOLD $9.47
- Average True Range (ATR)
- HASI 0.80
- FOLD 0.30
- MACD
- HASI 0.19
- FOLD 0.04
- Stochastic Oscillator
- HASI 58.04
- FOLD 85.71
About HASI Hannon Armstrong Sustainable Infrastructure Capital Inc.
HA Sustainable Infrastructure Capital Inc is a climate investment firm that actively partners with clients to deploy real assets that facilitate the energy transition. It invests in behind-the-meter (BTM) building or facility-specific distributed energy projects which reduce energy usage or cost, Grid-connected (GC) renewable energy projects that deploy cleaner energy sources, such as solar, solar-plus-storage, and onshore wind, to generate power production and Fuels, Transport & Nature projects.
About FOLD Amicus Therapeutics Inc.
Amicus Therapeutics Inc is a biotechnology company focused on discovering, developing and delivering medicines for people living with rare metabolic diseases. The company is engaged in developing a pipeline of medicines for rare metabolic diseases, including a rare disease gene therapy portfolio. It has a portfolio of product opportunities, including oral precision medicine for people living with Fabry disease who have amenable genetic variants; a clinical-stage, treatment paradigm for Pompe disease, and a rare disease gene therapy portfolio. The company has one segment focused on the discovery, development, and commercialization of advanced therapies to treat a range of devastating rare and orphan diseases.